MELTF and Alzheimer disease: Nevertheless, our study implies that baseline CSF MTf levels may be a useful marker to identify individuals with increased risk of conversion to AD, although much development still needs to be undertaken to ensure robust assay reproducibility across multiple clinical laboratories.